The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
- 1 June 2021
- journal article
- review article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 6 (6) , 459-473
Abstract
No abstract availableKeywords
Funding Information
- Danone Nutricia Research
- Deutsche Forschungsgemeinschaft
- Falk Foundation
- ZonMw
- Kyowa Kirin
- Shire
- Bayer
This publication has 111 references indexed in Scilit:
- Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 StudyGastroenterology, 2013
- Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management websiteBMC Gastroenterology, 2013
- A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With ConstipationAmerican Journal of Gastroenterology, 2012
- Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2011
- Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2010
- Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2010
- The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel SyndromeDigestive Diseases and Sciences, 2009
- A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel SyndromeDigestion, 2008
- Identification of Patients with Non-D, Non-C Irritable Bowel Syndrome and Treatment with Renzapride: An Exploratory, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical TrialDigestive Diseases and Sciences, 2008
- Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled TrialDigestive Diseases and Sciences, 2007